Igniting medtech innovation: How GCMI assists university-based and physician innovators bring new products to market

  GCMI and T3 Labs CEO Tiffany Wilson shares medtech development pathway insights in Medical Product Outsourcing. Bringing a new medical device from concept to cure to commercialization is an intimidating, complex and expensive process which often stifles innovation instead of encouraging it. Yet there remains a tremendous need and viable markets for medtech innovation…

Meeting the top needs in preclinical studies for orthopedic devices: the first structural, completely porous bioactive glass

For medical product innovators large and small, T3 Labs prides itself on delivering the highest value preclinical testing and bioskills training services available. Once Bio2 Technologies reached the second stage in the process from concept to cure to commercialization – preclinical – they entrusted T3 Labs to deliver three consecutive studies for the first completely…

Influencing future innovators: T3 Labs speaks to the Georgia Tech Masters of Biomedical Innovation and Development class

The Masters of Biomedical Innovation and Development program (BioID program) is a collaborative academic experience in Biomedical technology and a hands-on clinical experience built upon the extraordinary resources and reputation of the Wallace H. Coulter Department of Biomedical Engineering: a joint department of the Georgia Tech College of Engineering and the Emory University School of Medicine.…

Aortic & mitral valves galore plus bioresorbable scaffold results: T3 Labs’ insights from TCT 2016

The Cardiovascular Research Foundation’s annual TCT conference serves as the premier cardiovascular event of the year: delivering the latest clinical and preclinical updates on a wide spectrum of transcatheter therapies and the 2016 edition was no exception. In addition to catching up with existing and prospective sponsors and FDA regulators, here are a few of…

Building bridges and learning about the latest in interventional neurovascular technology at the SVIN 2016

T3 Labs will be present at the Society of Vascular and Interventional Neurology (SVIN) annual meeting, which will be held November 16 – 19, 2016 in Brooklyn, New York. This is a great opportunity to learn about the latest clinical and scientific contributions in endovascular technologies and innovative approaches in the management of stroke and…

Breakthroughs in preventing and treating GI disorders: What we learned at ACG 2016

The American College of Gastroenterology annual conference serves as the premier gastrointestinal event of the year: delivering the latest clinical updates on a wide spectrum of GI disorders and the 2016 edition was no exception. The ACG’s mission is to advance world-class care for patients with gastrointestinal disorders using innovative methods in prevention and treatment.…

Navigating the medtech approval pathway: lessons learned from physician innovator Dr. Steven Goudy, MD.

Dr. Steven Goudy, MD, is an associate professor and Director of Pediatric Otolaryngology for the Emory School of Medicine. He recently took the time to sit down with our CEO Tiffany Wilson during a webinar highlighting how physician innovators should approach the medtech development and approval pathway to increase the odds of successfully completing the…

Meet us at TCT 2016

Transcatheter Cardiovascular Therapeutics (TCT) is the world’s foremost educational meeting specializing in interventional cardiovascular medicine. This year, TCT 2016 will be hosted October 29th – November 2nd in Washington D.C. The transcatheter cardiovascular innovation space is ever evolving which makes this conference valuable to the T3 Labs team- but we are particularly excited about TCT…